At BIDMC, our dedicated team is reimagining how health care is experienced and delivered, both on our Boston campus and around the world. Thanks in large part to philanthropy, BIDMC continues to make extraordinary strides across multiple disciplines—from the launch of new initiatives like our Heart Transplant Program to the development of cutting-edge treatments, such as a novel cancer vaccine. Read about more exciting innovations below.

BIDMC’s clinicians and researchers have an unwavering commitment to understanding and mitigating risk factors and eliminating barriers to care, helping to ensure brighter, healthier futures for all.

We invite you to get to know the experts who are helping to further enhance outcomes for our patients, while shaping the future of medicine.

Tyler Berzin, MD, led the first U.S. randomized control trial to demonstrate the benefit of AI for colorectal cancer screening, leading to FDA approval and improving precancerous polyp detection by 30 percent. 

Jennifer Ho, MD, is a cardiologist and leading researcher on heart failure with preserved ejection fraction, which has few treatments. Her ultimate goal is to better understand mechanisms of heart failure to enable disease prevention. 

Jacalyn Rosenblatt, MD, works with David Avigan, MD, and together they developed a translational research program in cellular immunotherapy, including a personalized cancer vaccine that they have taken from lab discoveries into multicenter clinical trials. 

Mouhsin Shafi, MD, PhD, uses noninvasive techniques such as Transcranial Magnetic Stimulation to investigate and modify human brain function, applicable in many psychiatric and neurological disorders. 

John Torous, MD, developed an app used as part of a novel treatment model that allows patients to be seen within two weeks of referral; traditional care models can have wait times exceeding three months. 

Ruth-Alma Turkson-Ocran, PhD, MPH, RN, studies innovative treatment approaches that address hypertension prevention and social determinants of cardiometabolic health among people of African descent, with the ultimate goal of decreasing health disparities and improving outcomes for underserved populations.  

To learn more about these individuals and their work, contact Noreen Mitchell, Vice President of Philanthropy at 617-667-1387 or by email.